DD209632A5 - Verfahren zur herstellung neuer additionssalze von sultamicillin - Google Patents

Verfahren zur herstellung neuer additionssalze von sultamicillin Download PDF

Info

Publication number
DD209632A5
DD209632A5 DD83250080A DD25008083A DD209632A5 DD 209632 A5 DD209632 A5 DD 209632A5 DD 83250080 A DD83250080 A DD 83250080A DD 25008083 A DD25008083 A DD 25008083A DD 209632 A5 DD209632 A5 DD 209632A5
Authority
DD
German Democratic Republic
Prior art keywords
sultamicillin
formula
salts
salt
crystalline
Prior art date
Application number
DD83250080A
Other languages
German (de)
English (en)
Inventor
Wayne E Barth
Vytautas J Jasys
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD209632A5 publication Critical patent/DD209632A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD83250080A 1982-04-23 1983-04-21 Verfahren zur herstellung neuer additionssalze von sultamicillin DD209632A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (1)

Publication Number Publication Date
DD209632A5 true DD209632A5 (de) 1984-05-16

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83250080A DD209632A5 (de) 1982-04-23 1983-04-21 Verfahren zur herstellung neuer additionssalze von sultamicillin

Country Status (27)

Country Link
US (1) US4432987A (xx)
EP (1) EP0092968B1 (xx)
JP (1) JPS58201792A (xx)
KR (1) KR860001279B1 (xx)
AU (1) AU536854B2 (xx)
CA (1) CA1187484A (xx)
CS (1) CS235320B2 (xx)
DD (1) DD209632A5 (xx)
DE (1) DE3362502D1 (xx)
DK (1) DK162168C (xx)
EG (1) EG16412A (xx)
ES (1) ES8406075A1 (xx)
FI (1) FI76092C (xx)
GR (1) GR78582B (xx)
HK (1) HK20588A (xx)
HU (1) HU187068B (xx)
IE (1) IE54628B1 (xx)
IL (1) IL68453A (xx)
NO (1) NO156202C (xx)
NZ (1) NZ203988A (xx)
PH (1) PH18035A (xx)
PL (1) PL134978B1 (xx)
PT (1) PT76587B (xx)
SG (1) SG104087G (xx)
SU (1) SU1138030A3 (xx)
YU (1) YU43170B (xx)
ZA (1) ZA832845B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
DE3688613T2 (de) * 1985-11-18 1994-01-13 Access Pharma Inc Polychelierende stoffe für abbildung- und spektralerhöhung (und spektrale verschiebung).
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
ES2183874T3 (es) * 1994-05-02 2003-04-01 Shionogi & Co Cristal derivado de pirrolidylthiocarbapenem, preparado liofilizado conteniendo dicho cristal y procedimiento para su produccion.
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US7304166B2 (en) 2002-08-29 2007-12-04 Taisho Pharmaceutical Co., Ltd. Benzenesulfonate salt of 4-fluoro-2-cyanopyrrolidine derivatives
WO2004085444A1 (en) * 2003-03-27 2004-10-07 Basilea Pharmaceutica Ag Cephalosporin in crystalline form
EP1677757A2 (en) * 2003-10-31 2006-07-12 Alza Corporation Compositions and dosage forms for enhanced absorption
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
TWI432422B (zh) 2007-08-22 2014-04-01 Astrazeneca Ab 環丙基醯胺衍生物
CA2966280A1 (en) 2007-10-26 2009-04-30 The Regents Of The University Of California Diarylhydantoin compounds
PE20120003A1 (es) * 2009-01-30 2012-02-12 Glaxosmithkline Llc Hidrocloruro de n-{(1s)-2-amino-1-[(3-fluorofenil)metil)etil}-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2-tiofenocarboxamida cristalino
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
CA2767785A1 (en) * 2009-07-10 2011-01-13 Evolva Ag Diyne compositions
SG183274A1 (en) 2010-02-18 2012-09-27 Astrazeneca Ab Processes for making cyclopropyl amide derivatives and intermediates associated therewith
CA2789884A1 (en) * 2010-02-18 2011-08-25 Astrazeneca Ab Solid forms comprising a cyclopropyl amide derivative
US9518004B2 (en) * 2012-12-03 2016-12-13 Kaneka Corporation Reduced coenzyme Q10 derivative and method for production thereof
KR20230159631A (ko) * 2013-09-05 2023-11-21 미쓰비시 타나베 파마 코퍼레이션 신규한 결정성 아릴알킬아민 화합물 및 그의 제조 방법
KR20210142781A (ko) * 2014-10-21 2021-11-25 다케다 야쿠힌 고교 가부시키가이샤 결정 형태의 5-클로로-n4-[2-(디메틸포스포릴)페닐]-n2-｛2-메톡시-4-[4-(4-메틸피페라진-1-일)피페리딘-1-일]피리미딘-2,4-디아민
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
CN108495844B (zh) * 2016-01-22 2022-12-02 桑多斯股份公司 结晶埃拉环素二盐酸盐
IL263996B2 (en) 2016-07-07 2024-03-01 Ironwood Pharmaceuticals Inc Solid configurations of the SGC promoter
EP3703686A4 (en) * 2017-10-30 2021-11-17 Theracaine LLC HYDROPHOBIC ARENE SULFONATE SALTS
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
ZA80796B (en) * 1979-02-13 1981-02-25 Leo Pharm Prod Ltd Chemical compounds
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
SG104087G (en) 1988-07-15
JPH0119395B2 (xx) 1989-04-11
JPS58201792A (ja) 1983-11-24
ZA832845B (en) 1984-11-28
DK101783A (da) 1983-10-24
KR840004437A (ko) 1984-10-15
DK162168B (da) 1991-09-23
NO156202B (no) 1987-05-04
AU1387183A (en) 1983-11-17
HU187068B (en) 1985-11-28
AU536854B2 (en) 1984-05-24
IE54628B1 (en) 1989-12-20
IL68453A (en) 1986-08-31
PL134978B1 (en) 1985-09-30
DK101783D0 (da) 1983-02-28
FI831392L (fi) 1983-10-24
PL241553A1 (en) 1983-11-21
CS235320B2 (en) 1985-05-15
YU43170B (en) 1989-04-30
DE3362502D1 (en) 1986-04-17
IE830926L (en) 1983-10-23
ES521728A0 (es) 1984-07-01
CA1187484A (en) 1985-05-21
PT76587A (en) 1983-05-01
EP0092968A1 (en) 1983-11-02
EG16412A (en) 1989-03-30
US4432987A (en) 1984-02-21
EP0092968B1 (en) 1986-03-12
YU90483A (en) 1986-04-30
FI76092B (fi) 1988-05-31
PH18035A (en) 1985-03-06
PT76587B (en) 1986-02-27
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
FI76092C (fi) 1988-09-09
DK162168C (da) 1992-03-02
KR860001279B1 (ko) 1986-09-05
FI831392A0 (fi) 1983-04-22
HK20588A (en) 1988-03-25
ES8406075A1 (es) 1984-07-01
GR78582B (xx) 1984-09-27
IL68453A0 (en) 1983-07-31
SU1138030A3 (ru) 1985-01-30
NO156202C (no) 1987-08-19

Similar Documents

Publication Publication Date Title
DD209632A5 (de) Verfahren zur herstellung neuer additionssalze von sultamicillin
DE1942693C2 (de) Verfahren zur Herstellung von (-)-α-Amino-p-hydroxybenzylpenicillintrihydrat
DE2332878C2 (de) Salze von Cephalosporinen mit Arginin und Lysin, ihre Herstellung und injizierbare pharmazeutische Zubereitungen
DE2713272C2 (de) Derivate der 7-Aminothiazolyl-acetamido-cephalosporansäure, ihre Herstellung und pharmazeutische Zusammensetzungen
DE3037102C2 (de) (6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)acetamido]-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylat-pentahydrat
DE2738712C2 (xx)
DE3018590A1 (de) Bisester von methandiol mit penicillinen und penicillansaeure-1,1-dioxid
DE2448966A1 (de) Penicillinderivate
CH647527A5 (de) Salz von 1,1-dioxopenicillanoyloxymethyl-6-(d-alpha-amino-alpha-phenylacetamido)-penicillanat, verfahren zu dessen herstellung sowie dieses salz enthaltende pharmazeutische praeparate.
CH646436A5 (de) Beta-lactamverbindungen, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen.
DE2524321A1 (de) Antibakterielle verbindungen,verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2056983B2 (de) S-Heterocyclylthiomethyl-Cephalosporine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2706548A1 (de) Amide der pseudomonsaeure, verfahren zu ihrer herstellung und ihre verwendung
DE2311346A1 (de) Penicilline und verfahren zu deren herstellung
DE2600842C2 (xx)
DE3008257A1 (de) Verfahren zur herstellung von penicillansaeure-1,1-dioxid und dessen estern sowie zwischenstufen zur durchfuehrung des verfahrens
DE2522998A1 (de) Neues cephalosporinderivat, verfahren zu seiner herstellung und arzneimittel
DE2716172C2 (de) Bis(6-[(hexahydro-1H-azepin-1-yl)-methylenamino]-penicillanoyloxy)-methan, seine Herstellung und dieses enthaltendes Arzneimittel
CH646176A5 (de) Beta-lactam-antibiotika mit beta-lactamase-hemmwirkung.
DE2801849A1 (de) Amino-spiro eckige klammer auf oxa- (oder thia-)-cycloalkan-penam eckige klammer zu -carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung
DE2655717A1 (de) Thiadiazolylderivate von 7-acylamido-3-cephem-4-carbonsaeure, verfahren zu deren herstellung und dieselben enthaltende pharmazeutische und veterinaermedizinische mittel
DE2244915A1 (de) Antibiotika und verfahren zu deren herstellung
DE2442302C2 (de) Cephalosporine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
DE1938052C3 (de) Antibiotische Siomycin A-Derivate und ihre Herstellung
DE3623900A1 (de) Ceph-3-em-4-carbonsaeure-derivat

Legal Events

Date Code Title Description
NAC Public notice for inspection of provisional exclusive patent accord. to par 18/2 dd-patg.
ENJ Ceased due to non-payment of renewal fee